Bainco International Investors’s Allogene Therapeutics ALLO Stock Holding History

Bainco International Investors’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$3.86M	Buy	152,839 +43,289	+40%	+$1.41M	0.44%	60
2020 Q3	$4.13M	Buy	109,550 +35,756	+48%	+$1.35M	0.52%	61
2020 Q2	$3.16M	Sell	73,794 -2,056	-3%	-$74.4K	0.45%	62
2020 Q1	$1.48M	Sell	75,850 -800	-1%	-$19.1K	0.26%	59
2019 Q4	$1.99M	Sell	76,650 -279,263	-78%	-$7.69M	0.28%	61
2019 Q3	$9.7M	Hold	355,913	–	–	1.5%	23
2019 Q2	$9.56M	Buy	355,913 +2,500	+0.7%	+$69.7K	1.51%	24
2019 Q1	$10.2M	Buy	+353,413	New	+$10.3M	1.66%	19

Other funds holding ALLO

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bainco International Investors's ALLO Position: Q4 2020 in Review

Bainco International Investors increased its Allogene Therapeutics (ALLO) stake by 40% in Q4 2020, buying an estimated $1.41M and bringing the position to 152,839 shares worth $3.86M. The position accounts for 0.44% of the portfolio, ranked #60.

Bainco International Investors first reported a position in ALLO in Q1 2019 and has held it in 8 quarters since. The position peaked at $10.2M in Q1 2019. 165 funds tracked by Wall St. Rank hold ALLO as of Q4 2020.

Bainco International Investors held 152,839 shares of Allogene Therapeutics worth $3.86M as of Q4 2020.
Bainco International Investors bought 43,289 Allogene Therapeutics shares in Q4 2020, an estimated $1.41M.
Allogene Therapeutics made up 0.44% of Bainco International Investors's portfolio in Q4 2020, its #60 holding.
Bainco International Investors first reported a position in Allogene Therapeutics in Q1 2019 and has held it in 8 quarters since.
Bainco International Investors's Allogene Therapeutics position peaked at $10.2M in Q1 2019.
165 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q4 2020.

Based on Bainco International Investors's 13F filing for Q4 2020, filed 12 Jan 2021.